< Back to situations

[PERSON]

Harlan Krumholz

Featured in 3 tracked stories · first seen

Situations

[ACTIVE] [HEALTH] [US] [GB] [SE]

Expanding therapeutic uses and regulatory approvals for GLP-

33 clusters · 154 sources · last updated

Latest: GLP-1 medications show weight loss challenges regarding muscle mass and maintenance

Medical research continues to expand the therapeutic potential of GLP-1 receptor agonists like semaglutide and tirzepatide. While semaglutide is widely used for weight loss and diabetes, new evidence suggests it may slow

Also covered in